Antisense & RNAi Therapeutics Market
Antisense & RNAi Therapeutics Market Overview 2024-2030 - Global Antisense & RNAi Therapeutics Market Forecast to Reach $14.4 Billion by 2030
12 nov. 2024 05h33 HE | Research and Markets
Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for...
22157.jpg
RNAi Market and Technologies Industry Report 2024, with Company Profiles of Major Players including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity
23 août 2024 04h02 HE | Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for RNAi technology is estimated to...
Global Exosome Diagnostics and Therapeutics Market
Exosome Diagnostics and Therapeutics Research Report 2024: Market to Grow at a Staggering CAGR of 81.2% by 2032
02 août 2024 10h48 HE | Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source...
Logo Resized for Globe Newswire2.jpg
Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
12 juin 2024 08h30 HE | Wave Life Sciences USA, Inc.
Presentation at the Obesity & Weight Loss Drug Development Summit to review Real World Evidence for the GLP-1 class and the opportunity for Wave’s INHBE program as a best-in-class approach for...
22157.jpg
Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Report 2024: USA Dominating with 5 Therapies, FDA Orphan Designation, Proprietary Development Technologies by Companies
14 mai 2024 05h38 HE | Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global PIM Kinase Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering....
Global RNAi Therapeutics Market
Global RNAi Therapeutics Market Analysis Report 2024-2028: Progress in Collaborations & Associated Deals Bodes Well for the Sector
01 mai 2024 09h16 HE | Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
22157.jpg
Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 - Groundbreaking Advances in PLK Targeted Therapies Promise to Revolutionize Treatment for Cancer and Other Diseases
29 avr. 2024 06h53 HE | Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's...
Global Antisense and RNAi Therapeutics Market
Global Antisense and RNAi Therapeutics Report 2024: A USD 34.7 Billion Predicted Market by 2034, with CAGR of 18% During 2024-2034
16 avr. 2024 07h26 HE | Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Antisense and RNAi Therapeutics Market" report has been added to ResearchAndMarkets.com's offering.The global antisense and RNAi therapeutics...
market-digits.jpg
Antisense RNAi Therapeutics Market projected to reach USD 14.3 Billion by 2030, growing at a CAGR of 17.2% during the forecast period of 2023-2030 - says MarketDigits in its latest study Richmond, March 04, 2024 (GLOBE NEWSWIRE) -- According to a research report "Antisense RNAi Therapeutics Market”, by Technology (RNA interference {siRNA, miRNA}, Antisense RNA and Others), Route of...
22157.jpg
Europe Nucleic Acid Therapeutics CDMO Market Analysis and Forecasts, 2023-2033: Increasing FDA or European Medicines Agency Approvals, Pharmaceutical Firms Becoming More Outsourcing-Oriented
28 févr. 2024 09h01 HE | Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Europe Nucleic Acid Therapeutics CDMO Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Europe...